Heart failure and apoptosis: electrophoretic methods support data from micro- and macro-arrays. A critical review of genomics and proteomics.
The multiple causes and multiple consequences of mammalian heart failure make it an attractive proposition for analysis using gene array technology, especially where the failure is idiopathic in nature. However, gene arrays also hold potential artefacts, particularly when gene expression levels are low, and where changes in expression levels are modest. Also, at present, the number of genes available on arrays is not large enough to prevent potential sampling deficiencies. Thus, it may not be wise to place too much reliance on quantitative interpretations of gene array data. Also, recently doubts were raised about the qualitative reliability of array genes. Electrophoretic methods are slow, cumbersome and complex but they can provide confirmation that the trends and numbers arising from the new gene arrays are reliable. In this overview, we compare gene array data with data from protein activity assays such as zymograms, Western blots, two-dimensional electrophoresis, and immunohistochemistry. Similar or complementary data from the same heart tissues analyzed by either microarrays or macroarrays can be reassuring to those interested in reliable molecular analyses of normal and failing hearts. Similar principles will apply to other tissues and cells.
Jiang
L
L
Institute for Biomedical Research, Department of Anatomy and Histology, University of Sydney, NSW, Australia.
Tsubakihara
M
M
Heinke
M Y
MY
Yao
M
M
Dunn
M J
MJ
Phillips
W
W
dos Remedios
C G
CG
Nosworthy
N J
NJ
D000818:Animals; D017209:Apoptosis; D015153:Blotting, Western; D004285:Dogs; D015180:Electrophoresis, Gel, Two-Dimensional; D016678:Genome; D006333:Heart Failure / Q000378:metabolism*; D020287:In Situ Nick-End Labeling; D008904:Miniaturization; D020411:Oligonucleotide Array Sequence Analysis; D020543:Proteome
D020543:Proteome